Ειδήσεις: LYME DISEASE | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

24/03 21:35 gizmodo.com

Finally, Some Good News in the Fight Against Lyme Disease

Lyme disease vaccine efficacy clinical trial tick-borne illness public health

23/03 18:29 thehill.com

Lyme disease vaccine 70 percent effective: Pfizer

Lyme disease vaccine Pfizer Valneva phase 3 trial tick‑borne illness

23/03 15:10 statnews.com

STAT+: Pfizer’s Lyme vaccine results set up tricky regulatory path

Pfizer Lyme disease vaccine Phase 3 regulatory efficacy

23/03 13:07 marketwatch.com

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Pfizer Valneva Lyme disease vaccine late‑stage trial regulatory approval

23/03 13:07 marketwatch.com

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Pfizer Valneva Lyme disease vaccine late‑stage trial regulatory approval

Loading...